Cargando...
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes
The discovery of JAK2(V617F) a decade ago led to optimism for a rapidly developing treatment revolution in Ph(−) myeloproliferative neoplasms. Unlike BCR–ABL, however, JAK2 was found to have a more heterogeneous role in carcinogenesis. Therefore, for years, development of new therapies was slow, des...
Gardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844455/ https://ncbi.nlm.nih.gov/pubmed/27143923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S83868 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|